The past eight years have seen massive strides
forward for the field of genome editing, thanks to a new technology known as
CRISPR. This newfound ability to edit humanity’s genetic code provides both
profound opportunities for human betterment and difficult ethical questions
about how far the technology should be permitted to go. Kevin Davies and I
recently discussed these questions on an episode of Political Economy.
Kevin is the executive editor of The CRISPR Journal and the founding editor of Nature Genetics. He is also the author of several books, including the recently released “Editing Humanity: The CRISPR Revolution and the New Era of Genome Editing.”
Below is an abbreviated transcript of our conversation. You can read our full discussion here. You can also subscribe to my podcast on Apple Podcasts or Stitcher, or download the podcast on Ricochet.
Your book’s title refers to the “CRISPR revolution.” How